T11	Effect 13 31	movement disorders
T12	Treatment 71 90	carbamazepine (CBZ)
T13	Subject 102 121;188 263	adults and children in patients with underlying Tourette's syndrome or other movement disorders
T15	Age 102 108	adults
T16	Age 113 121	children
T17	Drug 71 84	carbamazepine
T18	Sub-Disorder 217 235	ourette's syndrome
T19	Subject 245 263	movement disorders
